Winship Cancer Institute of Emory University announced that the Peyton Anderson Cancer Center, Navicent Health in Macon, Georgia, has joined the Winship Cancer Network.
Emory scientists show what molecular features distinguish the subset of T cells that wake up when re-energized by PD-1-blocking agents. Valuable for optimizing cancer immunotherapy and drug combinations.
Emory's Winship Cancer Institute is using new drugs that work with a patient's own immune system to fight cancer.
A research team from Emory University and Metaclipse Therapeutics Corp. is developing a new cancer vaccine immunotherapy targeting triple-negative breast cancer.
When doctors hurl toxic death at cancer cells, often a few will survive and come back. A family of enzymes called KDM5 histone demethylases is emerging as important for this resilience, and drugs that inhibit KDM5 enzymes could be active in treating several types of cancer.
Winship Cancer Institute medical oncologist Taofeek Owonikoko, MD, PhD is one of 13 recipients of the 2016 National Cancer Institute (NCI) Cancer Clinical Investigator Team Leadership Award (CCITLA).
President Carter talks about his cancer diagnosis and treatment and recognizes the role research has played in making advanced treatments possible for patients like him.
Many common medical treatments have never been tested in a clinical trial. A new study published in the July issue of Health Affairs highlights how evidence from trials of untested but widely used treatments can change medical practice and help patients.
The healing arts program at Winship Cancer Institute of Emory University at Emory Johns Creek Hospital (EJCH) is helping patients in their fight against cancer.
The "oncometabolite" D-2-hydroxyglutarate, produced by some brain tumors, can be detected by mass spectrometry in cerebrospinal fluid.